Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Blinatumomab: a Bispecific CD19-Directed CD3 T-Cell Engager | Value ...
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is ...
A Novel bispecific T-cell engager (BiTE) targeting CD22 and CD3 has ...
BCMA x CD3 T-cell engager in a patient with pentarefractory multiple ...
FDA Approval Summary: Teclistamab–A Bispecific CD3 T-Cell Engager for ...
FDA Approval Summary: Teclistamab–A Bispecific CD3 T-cell Engager for ...
B7-H6/CD3 T-cell engager | InOncology – Boehringer Ingelheim
A Review of T Cell Markers, CD3 Antigens and Antibodies - Creative ...
B7-H6/CD3 T-cell Engager | Clinical Research | InOncology
DLL3/CD3 T-cell Engager | Clinical Research | InOncology
DLL3/CD3 T-cell engager | InOncology – Boehringer Ingelheim
Mechanism of action of BiTE technology. BiTE bispecific T cell engager ...
Bispecific dendritic-T cell engager potentiates anti-tumor immunity: Cell
Bispecific T Cell Engager Assays | In Vitro Assays Services | WuXi ...
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked ...
A general schematic outlining the structure of bivalent T cell engager ...
Schematic illustration of Bispecific T-cell Engager (BiTE) structure ...
Bispecific T-Cell Engager for Targeted Cancer Immunotherapy | Moffitt
1068 ATG-107, a novel 2+1 CD3-based T cell engager (TCE) targeting FLT3 ...
CD3 bispecific antibody–induced cytokine release is dispensable for ...
Murine CD3 and fibroblast activation protein‑T‑cell engager‑armed ...
Full article: Phase I trial of the DLL3/CD3 bispecific T-cell engager ...
Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule ...
Bi-specific T-cell engager treatment leads to depletion of patients ...
Figure 1 from GBR1302: Effect of CD3-HER2, a bispecific T cell engager ...
Unlocking the Power of CD3 × B Cell Bispecific Antibodies with ...
Bispecific T Cell Engager for Cancer Therapy | SpringerLink
Bispecific T-cell Engager (CD3 × EGFR)-Based Triplet Therapy Unlocks ...
Combining CD3/GD2 bispecific T cell engager with human Vγ9Vδ2 T cells ...
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in ...
CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell ...
Human endoglin-CD3 bispecific T cell engager antibody induces anti ...
Immunofluorescence analysis of bispecific T-cell engager (BiTE) forming ...
The CD34-specific bi-specific T-cell engager efficiently depletes ...
Bispecific antibody binding to human T cell CD3 and cytokine release. T ...
Figure 2 from Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with ...
An affinity-modulated T cell engager targeting Claudin 18.2 shows ...
Overview of mechanisms of bispecific T-cell engager (BiTE) therapy and ...
Rethinking T Cell Engager Design: CD3–TAA Affinity Co-Optimization Matters
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager ...
Innovations in cancer immunotherapy: Bi-specific T cell engagers | CAS
Human Cord Blood CD3+ T Cells, Pure and Viable | HumanCellsBio.com ...
T-Cell Engagers—The Structure and Functional Principle and Application ...
Bispecific antibodies comparison to Bispecific T-cell Engager. BiTEs ...
Bispecific T cell engagers | Proteintech Group
T-cell-engaging bispecific antibodies in cancer - The Lancet
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer ...
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next ...
Masking bispecific T cell engagers until they reach the tumor improves ...
T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma—An Update
Selected signalling proteins recruited to the T‐cell receptor–CD3 ...
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell ...
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma ...
Frontiers | The making of multivalent gamma delta TCR anti-CD3 ...
Bispecific T Cell Engagers and Synthetic Immunity: Circumventing Immune ...
Frontiers | Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3
Bispecific T-Cell Engagers for Cancer Immunotherapy
Structural design and biochemical properties of bispecific T-cell ...
Science BiTE/BAFF-R BiTE 2 - PeproMene Bio IncPeproMene Bio Inc
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma ...
A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti ...
GRAPHIC
SITC 2023: Preclinical CD3-based Mouse Models for Evaluation of Bi ...
Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer ...
Anti-human CD3-CD28 | For T cell expansion and Activation | InvivoGen
CD3‐T‐cell‐engager (TCE) therapies to overcome solid tumors: Beyond ...
T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions
Conditionally active T-cell engager. Various approaches to ...
Frontiers | Revolutionizing cancer treatment: the power of bi- and tri ...
Bispecific Antibodies for Triple Negative Breast Cancer: Trends in Cancer
T cell-engager：产生应答的T cells表型详解_生物器材网
Frontiers | Perspective: Designing T-Cell Engagers With Better ...
Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell ...
Bispecific Antibodies: Expanding the Frontiers of Targeted Immunotherapy
你了解CD3双抗开发中的“坑”吗？ - 企业动态 - 丁香通
Bispecific T cell engagers and their synergistic tumor immunotherapy ...
Frontiers | Advancing Cancer Therapy with Present and Emerging Immuno ...
Bi-specific T-cell engager-induced interaction and killing leads to ...
Tarlatamab-dlle Approved for Metastatic Lung Cancer | AACR
Nano-bispecific-engager for enhancing T cell function. (A) Design and ...
Frontiers | Current landscape and future directions of bispecific ...
Figure 7 from A First-in-Class Pronectin™-based Bispecific T Cell ...
Figure 1 from Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell ...
T Cell Engagers: A Dual Breakthrough in Cancer and Autoimmune Therapy
T cell engager（TCE）双特异性抗体研发策略医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Molecular Construction of T Cell Engagers: Formats Matter
00521-4/asset/aeff7b5c-bffe-45e8-9371-0aac55a5dec4/main.assets/gr1_lrg.jpg)
